1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Medicine Science & Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

CME credits: 0.50
Valid until: 23-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/time-out-a-case-based-deep-dive-into-the-challenges-of-aria-management/26588/

Amyloid-rela…

Mon 23 Dec 2024
Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma

Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma

Fri 20 Dec 2024
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH

Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH

CME credits: 1.00
Valid until: 20-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/pulmonary-hypertension-comorbidities-with-pah-and-group-2-ph/28869/

Providers face challen…

Fri 20 Dec 2024
Emerging immunotherapy combination strategies in genitourinary malignancies

Emerging immunotherapy combination strategies in genitourinary malignancies

CME credits: 1.25
Valid until: 20-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/emerging-immunotherapy-combination-strategies-in-genitourinary-malignancies/29201/

This on…

Fri 20 Dec 2024
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies

Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies

Fri 20 Dec 2024
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma

Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma

Fri 20 Dec 2024
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

Fri 20 Dec 2024
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

Fri 20 Dec 2024
Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer

Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer

Fri 20 Dec 2024
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

CME credits: 1.00
Valid until: 20-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/risk-assessment-in-pulmonary-hypertension-practice-trends-and-updates/28867/

Hear about th…

Fri 20 Dec 2024
Pulmonary Hypertension Management: Practice Trends and Updates

Pulmonary Hypertension Management: Practice Trends and Updates

CME credits: 1.00
Valid until: 20-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/pulmonary-hypertension-management-practice-trends-and-updates/28868/

The landscape of medi…

Fri 20 Dec 2024
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy

Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy

Fri 20 Dec 2024
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma

Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma

Fri 20 Dec 2024
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

Fri 20 Dec 2024
Emerging targeted therapy combination strategies in genitourinary malignancies

Emerging targeted therapy combination strategies in genitourinary malignancies

Fri 20 Dec 2024
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs

An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs

Thu 19 Dec 2024
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

Wed 18 Dec 2024
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance

Biologic Rationale for Targeting HER3 and Role in EGFR Resistance

CME credits: 0.75
Valid until: 17-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/biologic-rationale-for-targeting-her3-and-role-in-egfr-resistance/26456/

Since the develop…

Tue 17 Dec 2024
Overcoming EGFR Resistance With HER3-Directed ADCs

Overcoming EGFR Resistance With HER3-Directed ADCs

CME credits: 0.75
Valid until: 17-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/overcoming-egfr-resistance-with-her3-directed-adcs/26457/

Since the development of this ed…

Tue 17 Dec 2024
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs

Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs

CME credits: 0.75
Valid until: 17-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/interprofessional-monitoring-and-management-of-aes-with-her3-directed-adcs/26458/

Since th…

Tue 17 Dec 2024
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.